Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia
- 25 Downloads
Hyperbilirubinemia is commonly observed in patients requiring pancreatoduodenectomy (PD). Thus far, literature regarding the danger of operating in the setting of hyperbilirubinemia is equivocal. What remains undefined is at what specific level of bilirubin there is an adverse safety profile for undergoing PD. The aim of this study is to identify the optimal safety profile of patients with hyperbilirubinemia undergoing PD.
Patients and Methods
The present work analyzed 803 PDs from 2004 to 2018. A generalized additive model was used to determine cutoff values of total serum bilirubin (TB) that were associated with increases in adverse outcomes, including 90-day mortality. Subgroup comparisons and biliary stent-specific analyses were performed for patients with TB below and above the cutoff.
TB of 13 mg/dL was associated with an increase in 90-day mortality (P = 0.043) and was the dominant risk factor on multivariate logistic regression [odds ratio (OR) 8.193, P = 0.001]. Increased TB levels were also associated with reoperations, number of complications per patient, and length of stay. Patients with TB greater than or equal to 13 mg/dL (TB ≥ 13) who received successful biliary decompression through stenting had less combined death and serious morbidity (P = 0.048).
Preoperative TB ≥ 13 mg/dL was associated with increased 90-day mortality after PD. Reducing a TB ≥ 13 is generally recommended before proceeding to surgery.
- 5.Plusa S, Webster N, Primrose J. Obstructive jaundice causes reduced expression of polymorphonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in vitro. Gut. 1996;38(5):784–7. http://www.ncbi.nlm.nih.gov/pubmed/8707129. Accessed December 11, 2018.CrossRefGoogle Scholar
- 12.Gilsdorf RB, Spanos P. Factors influencing morbidity and mortality in pancreaticoduodenectomy. Ann Surg. 1973;177(3):332–7. http://www.ncbi.nlm.nih.gov/pubmed/4540286. Accessed December 11, 2018.
- 15.Scheufele F, Schorn S, Demir IE, et al. Preoperative biliary stenting versus operation first in jaundiced patients due to malignant lesions in the pancreatic head: a meta-analysis of current literature. Surgery. 2017;161(4):939–50. https://doi.org/10.1016/j.surg.2016.11.001.CrossRefPubMedGoogle Scholar
- 19.Vollmer CM, Lewis RS, Hall BL, et al. Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the accordion severity grading system, and the postoperative morbidity index. Ann Surg. 2015;261(3):527–36. https://doi.org/10.1097/sla.0000000000000843.CrossRefPubMedGoogle Scholar
- 31.Crippa S, Cirocchi R, Partelli S, et al. Systematic review and meta-analysis of metal versus plastic stents for preoperative biliary drainage in resectable periampullary or pancreatic head tumors. Eur J Surg Oncol. 2016;42(9):1278–85. https://doi.org/10.1016/j.ejso.2016.05.001.CrossRefPubMedGoogle Scholar
- 36.Mansfield SD, Sen G, Oppong K, et al. Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy - implications for timing of resectional surgery and use of biliary drainage. HPB. 2006. https://doi.org/10.1080/13651820600919860.CrossRefPubMedPubMedCentralGoogle Scholar